BCAX's three largest insider shareholders as of May 14, 2026 are Kiran Mazumdar-Shaw (Director, 6.28Mn shares), Kiran Mazumdar-Shaw (Director, 6.28Mn shares), Kiran Mazumdar-Shaw (Director, 6.28Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Kiran Mazumdar-Shaw | - | 0 | 6,281,185 | 16 Sep, 2024 |
| Kiran Mazumdar-Shaw | - | 0 | 6,281,185 | 16 Sep, 2024 |
| Kiran Mazumdar-Shaw | - | 0 | 6,281,185 | 16 Sep, 2024 |
| Ltd Biocon | - | 0 | 5,523,897 | 16 Sep, 2024 |
| Ltd Biocon | - | 0 | 5,523,897 | 16 Sep, 2024 |
| Ltd Biocon | - | 0 | 5,523,897 | 16 Sep, 2024 |
| Capital Management, L.P. Ra | - | 0 | 4,603,418 | 02 Mar, 2026 |
| Gp A, Llc Tpg | - | 0 | 1,960,425 | 18 Sep, 2024 |
| Gp A, Llc Tpg | - | 0 | 1,960,425 | 18 Sep, 2024 |
| Gp A, Llc Tpg | - | 0 | 1,960,425 | 18 Sep, 2024 |
| James E Flynn | - | 0 | 1,795,174 | 17 Sep, 2024 |
| James E Flynn | - | 0 | 1,795,174 | 17 Sep, 2024 |
| James E Flynn | - | 0 | 1,795,174 | 17 Sep, 2024 |
| Llc Fmr | - | 0 | 1,115,333 | 18 Sep, 2024 |
| Ltd Fil | - | 0 | 1,013,853 | 18 Sep, 2024 |
| Claire Mazumdar | Chief Executive Officer | 362,152 | 0 | 20 Apr, 2026 |
| Claire Mazumdar | Chief Executive Officer | 362,152 | 0 | 20 Apr, 2026 |
| Ryan Cohlhepp | President And Coo | 200,641 | 0 | 17 Mar, 2026 |
| Ryan Cohlhepp | President And Coo | 196,141 | 0 | 17 Apr, 2026 |
| Ryan Cohlhepp | President And Coo | 196,141 | 0 | 17 Apr, 2026 |
| Ivan Hyep | Chief Financial Officer | 145,355 | 0 | 22 Apr, 2026 |
| David Raben | Chief Medical Officer | 55,286 | 0 | 26 Mar, 2026 |
| David Raben | Chief Medical Officer | 55,286 | 0 | 26 Mar, 2026 |
| David Raben | Chief Medical Officer | 55,286 | 0 | 26 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 21 Apr, 2026 | Ivan Hyep | Common Stock | A | 9,200 | $3.79 | 154,555 | D | M |
| 21 Apr, 2026 | Ivan Hyep | Common Stock | A | 9,200 | $3.79 | 154,555 | D | M |
| 21 Apr, 2026 | Ivan Hyep | Common Stock | A | 9,200 | $3.79 | 154,555 | D | M |
| 21 Apr, 2026 | Ivan Hyep | Common Stock | A | 9,200 | $3.79 | 154,555 | D | M |
| 21 Apr, 2026 | Ivan Hyep | Common Stock | A | 9,200 | $3.79 | 154,555 | D | M |
| 21 Apr, 2026 | Ivan Hyep | Common Stock | D | 9,200 | $23.00 | 145,355 | D | S |
| 21 Apr, 2026 | Ivan Hyep | Common Stock | D | 9,200 | $23.00 | 145,355 | D | S |
| 21 Apr, 2026 | Ivan Hyep | Common Stock | D | 9,200 | $23.00 | 145,355 | D | S |
| 21 Apr, 2026 | Ivan Hyep | Common Stock | D | 9,200 | $23.00 | 145,355 | D | S |
| 21 Apr, 2026 | Ivan Hyep | Common Stock | D | 9,200 | $23.00 | 145,355 | D | S |
| 21 Apr, 2026 | Ivan Hyep | Stock Option (Right to Buy) | D | 9,200 | $0.00 | 39,744 | D | M |
| 21 Apr, 2026 | Ivan Hyep | Stock Option (Right to Buy) | D | 9,200 | $0.00 | 39,744 | D | M |
| 21 Apr, 2026 | Ivan Hyep | Stock Option (Right to Buy) | D | 9,200 | $0.00 | 39,744 | D | M |
| 21 Apr, 2026 | Ivan Hyep | Stock Option (Right to Buy) | D | 9,200 | $0.00 | 39,744 | D | M |
| 21 Apr, 2026 | Ivan Hyep | Stock Option (Right to Buy) | D | 9,200 | $0.00 | 39,744 | D | M |
| 16 Apr, 2026 | Claire Mazumdar | Common Stock | A | 8,226 | $4.44 | 347,618 | D | M |
| 16 Apr, 2026 | Claire Mazumdar | Common Stock | A | 7,454 | $3.79 | 355,072 | D | M |
| 16 Apr, 2026 | Claire Mazumdar | Common Stock | A | 7,080 | $5.45 | 362,152 | D | M |
| 20 Apr, 2026 | Claire Mazumdar | Common Stock | A | 15,000 | $3.79 | 377,152 | D | M |
| 20 Apr, 2026 | Claire Mazumdar | Common Stock | D | 15,000 | $23.61 | 362,152 | D | S |